NEW YORK and LOS ANGELES, July 1 (Reuters) – Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.
Source: Financials
